Baxter International (BAX) vs Utah Medical Products (UTMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Utah Medical Products (UTMD) has outperformed Baxter International (BAX) over the past year, gaining 16.5% versus a gain of 5.1%. Over five years, UTMD leads with a -17.9% price change compared with -70.0% for BAX. Baxter International is the larger company by market cap ($12.36 billion vs $234.5 million), about 52.7 times the size.
Utah Medical Products offers the higher dividend yield (1.67% vs 0.84%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BAX | UTMD |
|---|---|---|
| Share price | $23.91 | $73.88 |
| Market cap | $12.36B | $234.47M |
| 1-day change | 0.00% | 0.00% |
| YTD return | +25.07% | +32.01% |
| 1-year return | +5.05% | +16.47% |
| 5-year return | -70.01% | -17.93% |
| P/E ratio (TTM) | — | 22.52 |
| Forward P/E | 11.72 | — |
| EPS (TTM) | $-1.88 | $3.28 |
| Dividend yield | 0.84% | 1.67% |
| Annual dividend | $0.20 | $1.24 |
| Revenue (latest FY) | $11.24B | — |
| Revenue growth (YoY) | +5.72% | — |
| Net income (latest FY) | $-957.00M | — |
| Gross margin | 30.05% | — |
| Operating margin | -2.74% | — |
| Net margin | -8.51% | — |
| 52-week high | $30.00 | $76.89 |
| 52-week low | $15.73 | $53.66 |
| Distance from 52-week high | -20.30% | -3.92% |
| Analyst consensus | hold | — |
| Avg. price target upside | +16.77% | — |
| Average volume | 6.66M | 34.56K |
| Shares outstanding | 517.00M | 3.17M |
| Employees | 37,500 | 140 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Baxter International is about 52.7 times larger than Utah Medical Products by market value ($12.36B vs $234.47M).
- UTMD has outperformed BAX by 11.4 percentage points over the past year.
About Baxter International
BAX stock →Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals.
Health Care · Medical/Dental Instruments · 37,500 employees
About Utah Medical Products
UTMD stock →Utah Medical Products, Inc. offers medical devices for the healthcare industry in the United States, Europe, and internationally.
Health Care · Medical/Dental Instruments · 140 employees
BAX vs UTMD FAQ
Which is bigger, Baxter International or Utah Medical Products?
Baxter International (BAX) is larger, with a market capitalization of $12.36B compared with $234.47M for Utah Medical Products (UTMD).
Which stock has performed better over the past year, BAX or UTMD?
UTMD returned +16.47% over the past 12 months, compared with +5.05% for BAX (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Baxter International or Utah Medical Products?
Utah Medical Products has the higher yield at 1.67%, compared with 0.84% for Baxter International.
Are Baxter International and Utah Medical Products in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.